title: 5-Fluorouracil-induced coronary spasm: may inhibition of hyperpolarization factors produced by CYP2C enzymes be the cause?
authors.forename: Omer
authors.initials: O
authors.lastname: Karadag
authors.forename: Melih Onder
authors.initials: MO
authors.lastname: Babaoglu
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
authors.forename: Tamer
authors.initials: T
authors.lastname: Elkiran
authors.forename: Umit
authors.initials: U
authors.lastname: Yasar
authors.forename: Atila
authors.initials: A
authors.lastname: Bozkurt
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D001189:Aryl Hydrocarbon Hydroxylases / Q000378:metabolism*; D003329:Coronary Vasospasm / Q000139:chemically induced* / Q000201:enzymology* / Q000378:metabolism; D065729:Cytochrome P-450 CYP2C9; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans
chemical_list: D000964:Antimetabolites, Antineoplastic; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases; D005472:Fluorouracil